Home/Filings/4/0001185185-15-003190
4//SEC Filing

U.S. Stem Cell, Inc. 4

Accession 0001185185-15-003190

$USRMCIK 0001388319operating

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:01 PM ET

Size

8.2 KB

Accession

0001185185-15-003190

Insider Transaction Report

Form 4
Period: 2015-11-02
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2015-11-02+291,885342,284 total
    Exercise: $1.71From: 2015-11-02Exp: 2025-11-02Common Stock (291,885 underlying)
  • Award

    Stock Option (right to buy)

    2015-11-02+10,00050,399 total
    Exercise: $6.24Exp: 2025-11-02Common Stock (10,000 underlying)
Holdings
  • Common Stock

    6,578,947
Footnotes (1)
  • [F1]2,500 vest on 11/02/2016, 2,500 vest on 11/02/2017, 2,500 vest on 11/02/2018, 2,500 vest on 11/02/2019.

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001388319

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:01 PM ET
Size
8.2 KB